Excellence in robotics
for interventional vascular medicine
We work closely with healthcare professionals to develop robotic solutions for treating vascular diseases such as heart attack and stroke.
Our first solution, R-One™¹, is designed to assist with PCI, the established standard treatment for coronary artery diseases.
¹ CE-mark pending
This robotic unit perfectly reproduces hand movements and offers new possibilities: infinite repeatability and continuous movement.
Navigation is extremely precise, optimizing the placement of balloons and stents.
The guidewire locking system guarantees secure access to the lesion throughout the procedure.
Safe and reliable medical procedures
thanks to robotic assistance
INTUITIVE CONTROL
PRECISE AND SAFE NAVIGATION
UNIVERSAL OPEN ARCHITECTURE
COMPATIBLE WITH ALL MEDICAL DEVICES* *GUIDEWIRES AND STENT/BALLOON CATHETERS
The control unit allows physicians to manipulate instruments remotely. They can thus be protected from x-rays, known to cause serious diseases such as cancer².
The doctor can carry out procedures in a completely safe environment, while comfortably seated.
² Brain and neck tumors among physicians performing interventional procedures (2013)
Improving intervention conditions
RADIOPROTECTED CONTROL UNIT
REMOTE MANIPULATION
EASE OF USE
ERGONOMIC POSITION
OPTIMIZED PROCEDURE
Doctor J. Fajadet, co-director of the cardiovascular disease department at the Clinique Pasteur in Toulouse (France), co-director of EuroPCR congress and Director of the EAPCI
R-One™ is a very intuitive tool. Getting started is very fast and simple. In particular, R-One™ allows instruments to be locked into place, so you never lose access to the lesion. It brings a significant revolution in our profession.
Doctor R. Sabatier, interventional cardiologist at Caen University Hospital (France)
Getting started is very easy and intuitive. The fact that the robot’s behavior is consistent and means the risk of human error can be reduced.
Professor A. Cribier, Former Chief of the cardiology department at the university hospital of Rouen, conceived and developed the TAVI
R-One™ represents a major step forward in interventional cardiology. This technology really impressed me and will give strong benefits to the healthcare system.
Doctor A. Cremonesi, head of the Villa Maria hospital cardiovascular department in Bologna (Italy) and active member of EuroPCR Board
This robotic platform is very impressive. It’s the future of our profession, not only for interventional cardiology, but also for peripheral vascular and neurovascular procedures.
Palais du Pharo, Boulevard Charles Livon, Marseille, France
From 21 May 2019 to 24 May 2019
EuroPCR
Paris, France
About Robocath
Founded in 2009 by Philippe Bencteux, MD, Robocath designs, develops and commercializes robotic solutions to treat cardiovascular diseases. As an active player in the evolving medical robotic industry, these innovative solutions aim to make medical procedures safer, thanks to reliable technologies, while complementing manual interventions.
R-One™ is the first solution developed by Robocath. It uses a unique technology that optimizes the safety of robotic-assisted coronary angioplasty. It is designed to operate with precision and perform specific movements creating better interventional conditions. Thanks to its open architecture, R-One™ is compatible with market leading devices and cath labs.
Currently at the approval stage, R-One™ commercialization and clinical use will start in Europe in early 2019.
Robocath aims to become the world leader in vascular robotics and develop the remote treatment of vascular emergencies, guaranteeing the best care pathway for all.
